Nuveen
KRRO icon

Nuveen’s Korro Bio KRRO Stock Holding History

Nuveen’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Buy
+15,861
New +$197K ﹤0.01% 3629
2025
Q4 		– Sell
-9,264
Closed -$444K – 3275
2025
Q3 		$444K Buy
+9,264
New +$206K ﹤0.01% 2937
2025
Q2 		– Sell
-12,145
Closed -$211K – 3336
2025
Q1 		$211K Sell
12,145
-16,150
-57% -$479K ﹤0.01% 3124
2024
Q4 		$1.08M Buy
28,295
+17,131
+153% +$880K ﹤0.01% 2680
2024
Q3 		$373K Hold
11,164
– – ﹤0.01% 3100
2024
Q2 		$378K Buy
+11,164
New +$617K ﹤0.01% 3085
2022
Q2 		– Sell
-2,733
Closed -$4.96M – 3380
2022
Q1 		$4.96M Buy
2,733
+47
+2% +$8.98K ﹤0.01% 2066
2021
Q4 		$4.87M Sell
2,686
-226
-8% -$68.7K ﹤0.01% 2136
2021
Q3 		$5.28M Buy
2,912
+153
+6% +$60.2K ﹤0.01% 2179
2021
Q2 		$5.01M Buy
2,759
+764
+38% +$373K ﹤0.01% 2246
2021
Q1 		$3.62M Sell
1,995
-3
-0.2% -$5.83K ﹤0.01% 2327
2020
Q4 		$3.52M Buy
1,998
+4
+0.2% +$5.28K ﹤0.01% 2245
2020
Q3 		$1.92M Sell
1,994
-438
-18% -$470K ﹤0.01% 2404
2020
Q2 		$2.83M Buy
+2,432
New +$2.2M ﹤0.01% 2188

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Nuveen's KRRO Position: Q2 2026 in Review

Nuveen opened a new position in Korro Bio (KRRO) in Q2 2026: 15,861 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #3629 among its holdings. This is a return to the name: Nuveen previously reported a position in KRRO as recently as Q3 2025.

Nuveen first reported a position in KRRO in Q2 2020 and has held it in 14 quarters since. The position peaked at $5.28M in Q3 2021. 106 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Nuveen held 15,861 shares of Korro Bio worth $209K as of Q2 2026.
  • Korro Bio was a new Nuveen position in Q2 2026.
  • Korro Bio made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3629 holding.
  • Nuveen first reported a position in Korro Bio in Q2 2020 and has held it in 14 quarters since.
  • Nuveen's Korro Bio position peaked at $5.28M in Q3 2021.
  • 106 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.